ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Give Young Women Data, Not Guidelines, Advisors Tell NCI; consensus For Over 50

October 29, 1993

CGAP Speeding Gene Discovery

April 30, 1999

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

NCI Says. President Bush Visits NIH, Marks Decline In U.S. Cancer Deaths For Second Year.

January 19, 2007

NCAB Asks Speedup Of OSP Coordinating Center Review

October 14, 1983